Molecular therapy for Pulmonary Hypertension: Snail inhibits pulmonary hypertension via down regulation of its target gene, 19/January/2015, 8.04 am

MiRNA-based therapy for Human cancer: miRNA-5481 increases the expression of tumor suppressor p53 via down regulation of its target gene, 18/January/2015, 23.32
January 18, 2015
MiRNA-based therapy for p53-mutated human tumors: MiRNA-760 promotes the tumor suppressor function of TAp73, premature senescence and inhibits the expression of cancer stem cell genes via down regulation of its target gene, 19/January/20145, 8.47 am
January 19, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Pulmonary Hypertension: Snail inhibits pulmonary hypertension via down regulation of its target gene, 19/January/2015, 8.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Snail, by decreasing the expression of its target genes, it may inhibit pulmonary hypertension. Thus, pharmacological formulations encompassing “Snail activators”  may be used to treat pulmonary hypertension.

Amount: $ 300

Undisclosed information: How Snail inhibits the development of pulmonary hypertension

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.